Valerie Etzrodt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Valerie Etzrodt has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Ankita Garg
Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany
1 shared publicationAntje Prasse
Department of Respiratory Medicine and German Center for Lung Research, Hannover Medical School, Hannover, Germany
1 shared publicationBenjamin Seeliger
Department of Respiratory Medicine and German Center for Lung Research, Hannover Medical School, Hannover, Germany
1 shared publicationHeiko Schenk
Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
1 shared publicationHermann Haller
Division of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany
1 shared publicationHuihui Huang
Division of Nephrology, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
1 shared publication
Latest Publications
- 16 November 2024
- Published by Elsevier in Kidney International
- Vol. 107 (2) , 217-221
Advancing anti-inflammatory therapies: leveraging glucocorticoid pathways for novel treatments
- 16 November 2024
- Published by Elsevier in Kidney International
- Vol. 107 (2) , 217-221
Advancing anti-inflammatory therapies: leveraging glucocorticoid pathways for novel treatments
- Open Access
- 22 February 2021
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-12
Role of endothelial microRNA 155 on capillary leakage in systemic inflammation
Background: Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. Methods: SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Results: Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. Conclusions: We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.
- 22 February 2021
- Published by Springer Nature in Critical Care
- Vol. 25 (1) , 1-12
Open AccessRole of endothelial microRNA 155 on capillary leakage in systemic inflammation
Background: Capillary leakage is a key contributor to the pathological host response to infections. The underlying mechanisms remain incompletely understood, and the role of microRNAs (MIR) has not been investigated in detail. We hypothesized that specific MIRs might be regulated directly in the endothelium thereby contributing to vascular leakage. Methods: SmallRNA sequencing of endotoxemic murine pulmonary endothelial cells (ECs) was done to detect regulated vascular MIRs. In vivo models: transgenic zebrafish (flk1:mCherry/l-fabp:eGFP-DPB), knockout/wildtype mouse (B6.Cg-Mir155tm1.1Rsky/J); disease models: LPS 17.5 mg/kgBW and cecal ligation and puncture (CLP); in vitro models: stimulated human umbilical vein EC (HUVECs), transendothelial electrical resistance. Results: Endothelial MIR155 was identified as a promising candidate in endotoxemic murine pulmonary ECs (25 × upregulation). Experimental overexpression in a transgenic zebrafish line and in HUVECs was sufficient to induce spontaneous vascular leakage. To the contrary, genetic MIR155 reduction protects against permeability both in vitro and in endotoxemia in vivo in MIR155 heterozygote knockout mice thereby improving survival by 40%. A tight junction protein, Claudin-1, was down-regulated both in endotoxemia and by experimental MIR155 overexpression. Translationally, MIR155 was detectable at high levels in bronchoalveolar fluid of patients with ARDS compared to healthy human subjects. Conclusions: We found that MIR155 is upregulated in the endothelium in mouse and men as part of a systemic inflammatory response and might contribute to the pathophysiology of vascular leakage in a Claudin-1-dependent manner. Future studies have to clarify whether MIR155 could be a potential therapeutic target.